Exonuclease 1 genetic variant is associated with clinical outcomes of pemetrexed chemotherapy in lung adenocarcinoma

Pemetrexed is an anti-folate agent which is one of the most frequently used chemotherapy agents for non-squamous non-small cell lung cancer (NSCLC) patients. However, clinical response to pemetrexed chemotherapy and survival outcome of patients varies significantly. We evaluated whether the genetic...

Descripción completa

Detalles Bibliográficos
Autores principales: Hong, Mi Jeong, Park, Ji Eun, Lee, Shin Yup, Lee, Jang Hyuck, Choi, Jin Eun, Kang, Hyo-Gyoung, Do, Sook Kyung, Jeong, Ji Yun, Shin, Kyung Min, Lee, Won Ki, Seok, Yangki, Choi, Sun Ha, Lee, Yong Hoon, Seo, Hyewon, Yoo, Seung Soo, Lee, Jaehee, Cha, Seung Ick, Kim, Chang Ho, Park, Jae Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2022
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9809306/
https://www.ncbi.nlm.nih.gov/pubmed/36606188
http://dx.doi.org/10.7150/jca.78498

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9809306/
https://www.ncbi.nlm.nih.gov/pubmed/36606188
http://dx.doi.org/10.7150/jca.78498

Ejemplares similares